Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
0.60
-0.02 (-2.61%)
At close: Jul 02, 2025, 3:59 PM
0.61
0.78%
After-hours: Jul 02, 2025, 07:38 PM EDT

Relmada Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 13. The median target predicts an increase of 66.67% from the current stock price of 0.60.

Target Low Average Median High
Price 1 5 1 13
Change 66.67% 733.33% 66.67% 2066.67%

Latest Analyst Insight Report

According to 3 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating Sep 24 Dec 24
Strong Buy 10
Buy 00
Hold 02
Sell 00
Strong Sell 00
Total 1 2

Financial Forecast this Year

Revenue This Year
2.46M
from 0
Increased by -%
Revenue Next Year
10M
from 2.46M
Increased by 306.7%
EPS This Year
-1.93
from -2.65
Increased by 27.2%
EPS Next Year
-0.99
from -1.93
Increased by 48.7%